The effect of statin therapy on lipoprotein associated phospholipase A2 levels
about
Lp-PLA2 Inhibitors for the Reduction of Cardiovascular EventsRacial variation in lipoprotein-associated phospholipase A₂ in older adults.Lysophosphatidic acid in atherosclerotic diseasesLipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk.Lipoprotein-associated phospholipase A2 as a predictive biomarker of sub-clinical inflammation in cardiovascular diseases.Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A(2) fit in?The elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of apoB/Lp-PLA₂.Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study.High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction.Lipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target.Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patientsLipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker.Maternal Gestational Diabetes Mellitus increases placental and foetal lipoprotein-associated Phospholipase A2 which might exert protective functions against oxidative stress.Therapeutic Options to Reduce Lp-PLA2 Levels and the Potential Impact on Vascular Risk Reduction.Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction.Omega-3 fatty acids and lipoprotein associated phospholipase A(2) in healthy older adult males and females.Effects and potential mechanism of atorvastatin treatment on Lp-PLA2 in rats with dyslipidemia.
P2860
Q33936097-E346A85A-A48C-455F-887E-4E9FCAB93E30Q33946023-4E80FA07-E745-4CAD-BFED-67D0552C9572Q34273486-2EBE7C0A-944C-4473-A549-54903041D0C3Q34692452-5D78AF30-9A24-4D53-A0BC-E0F1A48579D7Q34890672-24BFAD22-4D1C-44E8-9876-BC79FC80C897Q35146962-F34305E2-11D9-4FD2-A1D5-17E9940B743CQ36024430-8B95F768-F1A3-4170-9A78-2F06CEA6C4A1Q36913018-9B5B8552-57E8-43D9-9B54-B6C8F2F3924DQ37305388-D87EB0D9-CFE9-41F6-82BC-8978B166DD95Q37328799-AF47FA7A-2484-460F-BE61-D760FD0A9512Q37386842-DFEE6638-0047-4F7C-97C1-EA706378222CQ37445865-06913652-A5DD-4787-8E20-B8390876EA3EQ37616607-F2A82703-7360-4DF0-A73F-E7CDCE4E7DF5Q37707415-DC8B7903-9188-47AA-A856-25ABFB2F295BQ42282625-CBC2CF52-5143-47F8-A974-C16CB4BF5AB0Q44652488-1AFFCE52-1F5F-42BF-979E-5BBEA9126895Q47103077-E30A75A1-6DA0-4CDD-98BF-E5764BDBE475Q51393272-57631953-2191-4ED7-835D-B47ECFCF27E7Q54109565-4AC8A08C-BC5A-4739-994F-3D5E9CC7FAD6
P2860
The effect of statin therapy on lipoprotein associated phospholipase A2 levels
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The effect of statin therapy on lipoprotein associated phospholipase A2 levels
@ast
The effect of statin therapy on lipoprotein associated phospholipase A2 levels
@en
The effect of statin therapy on lipoprotein associated phospholipase A2 levels
@nl
type
label
The effect of statin therapy on lipoprotein associated phospholipase A2 levels
@ast
The effect of statin therapy on lipoprotein associated phospholipase A2 levels
@en
The effect of statin therapy on lipoprotein associated phospholipase A2 levels
@nl
prefLabel
The effect of statin therapy on lipoprotein associated phospholipase A2 levels
@ast
The effect of statin therapy on lipoprotein associated phospholipase A2 levels
@en
The effect of statin therapy on lipoprotein associated phospholipase A2 levels
@nl
P2093
P1433
P1476
The effect of statin therapy on lipoprotein associated phospholipase A2 levels
@en
P2093
Michelle A Albert
Paul M Ridker
Robert J Glynn
Robert L Wolfert
P356
10.1016/J.ATHEROSCLEROSIS.2005.05.006
P407
P577
2005-09-01T00:00:00Z